[Chronic erythremic myelosis (or the chronic form of Di Guglielmo's disease). A case report]

Recenti progressi in medicina · 1999 · vol. 90(4) , pp. 213–5 · PMID:10354734 · W2411623138
Case report OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-13 ⓘ

This case report describes the temporary stabilization of hemoglobin and reduction of bilirubin and LDH levels in a patient with chronic erythromyelosis following intravenous gammaglobulin therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The chronic erythromyelosis (or chronic type of Di Guglielmo's disease) is a rare illness of uncertain classification. This illness shows characteristics that remember on the one hand the myeloproliferative and on the other hand the myelodysplastic diseases. The therapy is quite unsatisfactory. As a presence of erythrocytic antibodies has been detected, a therapy with steroids, danazol, splenectomy, immunosuppressive agents, plasmapheresis is advised. We have tried a cycle of therapy with high doses of intravenous gammaglobulin (0.4 g/kg/day for 4 days) also in the attempt of reduce, even if temporarily, the hemolytic component due to the reticuloendothelial system's hyperplasia. We conclude that this therapy, in our patient, has not yielded good outcomes immediately but carried out settled levels of haemoglobin as well as reduction of bilirubin and LDH after a month.

My notes (saved in your browser only)

MeSH descriptors

Leukemia, Erythroblastic, Acute Aged Chronic Disease Combined Modality Therapy Humans Leukemia, Erythroblastic, Acute Leukemia, Erythroblastic, Acute Male

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:53:16.030213+00:00
pubmed
last seen: 2026-10-08T20:58:57.924351+00:00
License: CC0 · commercial use OK